Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity - Wikidata - awgldk - TriplyDB

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

http://www.wikidata.org/entity/Q24535720

about

ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome Pathophysiology of thrombotic thrombocytopenic purpura Pathogenesis of thrombotic microangiopathies ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No The ADAMTS(L) family and human genetic disorders The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP)Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domain Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.The ADAMTS metalloproteinases Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.Flow-driven assembly of VWF fibres and webs in in vitro microvessels The interaction between factor H and Von Willebrand factor.A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry.A new name in thrombosis, ADAMTS13.A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods.Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow.von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.Cloning, expression and functional characterization of the full-length murine ADAMTS13.The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.von Willebrand factor: two sides of a coin.Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.Insights into von Willebrand factor proteolysis: clinical implications.Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura.Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.ADAMTS13 and microvascular thrombosis Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.The kidney in thrombotic thrombocytopenic purpura.The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy.

P2860

Q24534081-6D097FD9-CAC3-4E80-8D9C-6DB3294B8772 Q24614117-2251688D-A924-45ED-9BCF-7739C40E5F82 Q24658043-5DDB65D2-9388-4050-8E7E-8AEC75EF5571 Q26747656-B3DB4F99-9BC3-4A28-BBCC-DC017EC71B8B Q26827966-AA92849C-1870-4B80-82AE-1BC75D9E3899 Q28188189-2D9E4B9F-A18A-4924-B765-58C80A3342AB Q28188198-BEB3373A-A782-451D-9DDA-78516FE88CEF Q28246781-2477B2D3-66A5-4052-B85A-DB87E47E4366 Q28305837-6393BF3E-55B9-4529-85E5-B6C887305013 Q28564426-38538121-B72E-45AF-9962-FA590CECB8F4 Q28588904-CBFA85C1-D4BD-4251-ACE7-2495FB851E26 Q28591587-280EB313-64A6-4AC9-99F4-CF24D51CF1D0 Q28594414-781F40BF-5FA5-47DF-AC7F-3BA646357270 Q29544428-CE6F5B63-9C08-4C2B-A687-B5FA0F282DEF Q30543370-C65283EF-0949-4623-8C32-7E2B275568FD Q30659684-C69C8A60-7D14-42D9-B5B5-159DC55B127D Q31133820-D984E988-51A7-4C1D-B643-035DD5D87DCD Q33231922-05B7AE51-71D7-4449-AAB0-953D5F5BFB62 Q33343892-E23C1DC0-8756-436C-958C-3813E1705B7F Q33347147-F4D405C1-A2E9-4DD3-9703-51F409FF78C9 Q33349688-1A7794EE-D9F1-4BEA-B221-CEA7E8047C32 Q33359900-F07093BB-1336-4CE2-BE30-3C8836F13908 Q33359905-BB31E0EA-A7AD-473B-900F-7B8CFA1296E4 Q33360049-0DDAC371-CB4A-4B33-82B0-27C78B3AA6B1 Q33361703-A7A0B281-BFC5-41DB-A83B-D36230BFFDC7 Q33363572-400E245F-4367-484D-B67B-023206DD4DD4 Q33365643-439261B5-259F-4F0B-8E11-DF4C377DC6AF Q33366105-914E8D42-F122-4357-A26F-6576968162B0 Q33366493-23678524-9F6D-4B77-840E-5B3BCD8DEF2D Q33367858-1667636E-5EDD-4429-A091-DCDCDE792A49 Q33368779-8362E837-798F-4806-B0DB-470B31B07952 Q33369765-E71248CD-DD05-456C-920E-9BE7A012BB6F Q33369832-988D299D-F17A-4DA8-B481-8C977FFCFB65 Q33371131-4760C103-5796-4A99-9562-627B1B27C4DA Q33371690-770870AB-742A-4931-A136-8C240C4D4F8A Q33372115-A8331738-4182-4EC0-AF09-5392818D092E Q33373608-7972BE79-3C6D-4056-ADF3-33B56757D535 Q33376683-FF39DB8C-3D97-4E42-ABAD-45153EBAF5CA Q33378755-70EFC48F-2F15-4F57-91CA-C13D53D98E8C Q33380223-CDBC868B-3D17-4CF8-AFC3-8F4DB756C748

P2860

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

http://www.wikidata.org/entity/Q24535720

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Mutations and common polymorph ...... tor-cleaving protease activity

@ast

Mutations and common polymorph ...... tor-cleaving protease activity

@en

Mutations and common polymorph ...... tor-cleaving protease activity

@en-gb

Mutations and common polymorph ...... tor-cleaving protease activity

@nl

type

label

Mutations and common polymorph ...... tor-cleaving protease activity

@ast

Mutations and common polymorph ...... tor-cleaving protease activity

@en

Mutations and common polymorph ...... tor-cleaving protease activity

@en-gb

Mutations and common polymorph ...... tor-cleaving protease activity

@nl

prefLabel

Mutations and common polymorph ...... tor-cleaving protease activity

@ast

Mutations and common polymorph ...... tor-cleaving protease activity

@en

Mutations and common polymorph ...... tor-cleaving protease activity

@en-gb

Mutations and common polymorph ...... tor-cleaving protease activity

@nl

P1433

Q24535720-9D370D5B-4789-4E26-B844-395F6B288FD1

P1476

Q24535720-7D87A99D-EF08-4BCA-860C-BEAA0923D82D

P2093

Q24535720-244E8036-0D10-4C39-8C2C-87AA185DB95B

Q24535720-3F8CEAD0-EF40-4F09-920A-A8B123DE67D1

Q24535720-430AD837-394D-4B9E-8638-D42BA9861B3A

Q24535720-596A80F0-1E97-40A4-AF87-48C6F934204C

Q24535720-59F16238-D9CA-4A38-87FB-48F6E2296EA9

Q24535720-8BF85067-F2D4-4479-96A1-732FE3F5DF13

Q24535720-8CA60684-6E9F-4FC9-974D-D7897D23330E

Q24535720-A78A82C8-7DA7-4319-9F46-8B2D1B37E958

Q24535720-B0C89BA1-9E89-4CCC-A3ED-165124F60440

Q24535720-CB428F2E-036E-408C-97E6-28012251B096

P2860

Q24535720-097D6259-68A4-40EF-AB56-9B492B3B985D

Q24535720-14C88D0F-0C63-4449-BAB1-34BA12CD02BD

Q24535720-1520C767-697C-4739-B4C6-A2E5D1C1DB4C

Q24535720-1C323C70-5123-48BF-ACAE-22298C9C2ABB

Q24535720-2DF3307A-4D25-4120-999C-7F5DB5E5A5D7

Q24535720-3CA83CCC-3ED9-4880-8013-BA5F346C62AD

Q24535720-3D20715E-BEC5-45F4-A52A-541040DE3535

Q24535720-40107089-B686-4916-B14E-95BF304A7CE4

Q24535720-44184A43-B31E-4F58-BF7E-13473E13C2B2

Q24535720-4B8341E5-E2B8-45D5-BE82-68D2CA17744E

P304

Q24535720-17E28F9E-3780-44BF-8FC3-9CC9A4ED8957

P31

Q24535720-D1CC8227-CAF6-4873-B4E3-670C02CC67B2

P3181

Q24535720-92407F6D-9F45-4B07-AD59-76F92E2ACB06

P356

Q24535720-90B3EB44-C4FD-4FB6-9D89-E4333F4D5792

P407

Q24535720-213E8CC4-C730-4161-A0A3-C9AC5A3C43CF

P433

Q24535720-3728FB03-2786-4E12-AC63-FD5D2D0FAFD9

P478

Q24535720-A966A992-3BF0-4AFD-9BB2-F13E02D10D72

P577

Q24535720-DEDD3AF5-2B25-4080-911C-9F602B5C2170

P5875

Q24535720-036B8AFB-F5C9-4DCF-AFDC-8BC864E59DA9

P698

Q24535720-022A5B6F-9FE6-4AC6-9466-12884FA7704D

P932

Q24535720-86FE9046-B55E-4711-8CDD-E6724F2792A6

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Mutations and common polymorph ...... tor-cleaving protease activity

@en

P2093

Hideo Yagi

http://www.w3.org/2001/XMLSchema#string

Hiromichi Ishizashi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Tamai

http://www.w3.org/2001/XMLSchema#string

Kei Kamide

http://www.w3.org/2001/XMLSchema#string

Kenji Soejima

http://www.w3.org/2001/XMLSchema#string

Koichi Kokame

http://www.w3.org/2001/XMLSchema#string

Masahisa Funato

http://www.w3.org/2001/XMLSchema#string

Masanori Matsumoto

http://www.w3.org/2001/XMLSchema#string

Mutsuko Konno

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Miyata

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and genetics of von Willebrand factor

ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family

Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

Efficient selection for high-expression transfectants with a novel eukaryotic vector

ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats

Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome

Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3

The CUB domain. A widespread module in developmentally regulated proteins.

P304

11902-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1584506

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.172277399

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11204892

http://www.w3.org/2001/XMLSchema#string

P698

12181489

http://www.w3.org/2001/XMLSchema#string

P932

129366

http://www.w3.org/2001/XMLSchema#string